当前位置：首页 > 文献互助 > 互助详情

期刊论文Facile Production of 2,5-Furandicarboxylic Acid via Oxidation of Industrially Sourced Crude 5-Hydroxymethylfurfural复制

用户I4x09B0ykQvw 6天前 18 已关闭

DOI: 10.1002/ cssc.202102050复制

文献链接: https://doi.org/10.1002/cssc.202102050复制

其他信息:

上一篇：Facile Production of 2,5-Furandicarboxylic Acid via Oxidation of Industrially Sourced Crude 5-Hydroxymethylfurfural

下一篇：Facile Production of 2,5-Furandicarboxylic Acid via Oxidation of Industrially Sourced Crude 5-Hydroxymethylfurfural

互助时间线

2026-04-16 15:51:01 [关闭求助]

系统关闭了求助

备注: 重复求助，已回复上一条

2026-04-16 15:44:09 [发起求助]

最新发布的求助

Labeling-based centrality approaches for identifying critical edges on temporal graphs 37秒前

Effect of Fluid Restriction in Heart Failure: A Meta-Analysis of Randomized Controlled Trials 6分钟前

Protein-templated synthesis of dinucleotide repeat DNA by an antiphage reverse transcriptase 13分钟前

Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial 15分钟前

Postoperative recovery with remimazolam versus propofol in elderly patients undergoing daytime ocular fundus surgery under general anesthesia: a multicenter randomized non-inferiority trial 36分钟前

Quantitation of thiorphan in human plasma using LC-MS/MS and its application to a bioequivalence study 44分钟前

Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer 49分钟前

Advancing Seawater Electrolysis: NiFe‐LDH‐Based Electrocatalysts for the Oxygen Evolution Reaction 1小时前

Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial 1小时前

Over-testing for suspected pulmonary embolism in American emergency departments: the continuing epidemic 1小时前

Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial 1小时前

CLO26-102: Progression-Free Survival of Pembrolizumab Monotherapy Versus Combination Therapy With Chemotherapy as First-Line Treatment in Advanced or Metastatic Non-Small-Cell Lung Cancer Without EGFR/ALK Mutations 1小时前